The present study, to our knowledge, is the first to demonstrate presence of progesterone receptor (PR) transcript in human spermatozoa. The study shows the presence of low copy number PR mRNA in mature human spermatozoa. The PR transcript in spermatozoa was detected by reverse transcriptasepolymerase chain reaction using primers specific for the hormone binding domain and the DNA binding domain of the conventional uterine PR. Further, the cDNA sequence of the partial PR transcript from spermatozoa was found to be identical to the region spanning nucleotides 2694 to 3230 of the conventional PR full-length cDNA sequence. This study also indirectly suggests that the PR protein indeed is an intrinsic sperm protein and is not acquired through proteinaceous secretions of accessory reproductive organs.
INTRODUCTION
Recently a number of reports have suggested the role of progesterone, a typical female hormone, in various sperm functions, i.e., capacitation, acrosome reaction, motility, egg penetration, and fertilization [1] [2] [3] [4] [5] . There have been attempts to characterize the molecule(s) that mediates the progesterone-induced effects. Some of the studies succeeded in identifying and further characterizing the sperm proteins that bind to progesterone, conveniently termed progesterone receptors (PRs) [6] [7] [8] [9] [10] . The majority of these studies used competitive receptor inhibition assays, Western blotting, and fluorescein-tagged ligand binding tests to characterize the progesterone binding sites on human spermatozoa. However, these studies do not rule out the possibility of PR protein acquired by sperm through secretions of accessory reproductive organs. Detection of PR mRNAs in spermatozoa, a more reliable assay to ascertain whether the PR protein is actually synthesized in spermatids or spermatozoa, has not been attempted so far.
Interestingly, unlike conventional PRs, which act as intranuclear transcription factors in ovary, uterus, and mammary gland, sperm PR is a surface protein [11] . Further, there is evidence to suggest that the molecular mechanism of action of progesterone with respect to human spermatozoa differs from that commonly operating in other target tissues. Progesterone generally exerts its effects on the target tissues through its entry into the cells and binding to nuclear genomic receptors, with the subsequent activation of DNA transcription and protein synthesis [12] . However, DNA transcription and protein synthesis in the human spermatozoa, if present, are limited to mitochondria [13, 14] . The rapid modifying effects of progesterone on sperm motility, acrosome reaction, and metabolism are hardly compatible with a genomic effect [15] . The progesterone-mediated effects, for example, Ca 2ϩ influx into spermatozoa, are found to be too rapid to involve binding of the progesterone-PR complex to progesterone-responsive elements in DNA [16, 17] .
Further, ligand specificity experiments conducted in our laboratory demonstrated differences between sperm PR and uterine PR in their binding affinities to different ligands. Unlike uterine PR, sperm PR does not bind to mifepristone and other progesterone antagonists [11] .
Differences in the mode of action and the peculiar location of sperm PR as compared to the conventional PR prompted us to investigate 1) whether there exist any PR-like transcripts in mature human spermatozoa and 2) whether these resemble the conventional PR in terms of its genomic organization, i.e., the presence of an N-terminal domain, DNA binding domain, and hormone binding domain. In view of the emerging concept suggesting that the progesterone-PR complex in human spermatozoa apparently does not require interaction with DNA to induce biological effects, our study on the presence or absence of a DNA binding domain in PR transcripts in spermatozoa could be of great significance in understanding the nonclassical mode of action of steroids.
MATERIALS AND METHODS

Subjects
Semen samples were collected from healthy male volunteers, and endometrial biopsies were obtained from females attending the infertility clinic at the Institute for Research in Reproduction, Mumbai, India. Informed consent was obtained from each subject before collection of the samples.
Reverse Transcription (RT)-Polymerase Chain Reaction (PCR)
Motile spermatozoa were collected by swim-up of pooled semen samples [18] . In brief, pooled spermatozoa were washed twice with Dulbecco's modified Eagle's medium (DMEM; Sigma, St. Louis, MO) at 800 rpm for 10 min. Sixty million spermatozoa were overlaid with 1 ml of DMEM and incubated at 37ЊC for 1 h. Supernatants were pelleted at 800 rpm to obtain motile spermatozoa. Samples were checked under ϫ400 magnification using a brightfield light microscope (Zeiss Ultraphot; Carl Zeiss, Inc., Thornwood, NY) to rule out the possibility of any contamination with leukocytes or other debris. Total RNA was extracted from spermatozoa and endometrial aspirates using an RNeasy kit (Qiagen Inc., Santa Clarita, CA). Five micrograms of RNA was incubated with 5 units of ribonuclease-free deoxyribonuclease (DNase) I (Boehringer Mannheim, Mannheim, Germany) in single-strength reaction buffer at 37ЊC for 15 min. This was followed by heat inactivation of DNase I at 65ЊC for 10 min. DNase-treated RNA samples were Two hundred nanograms of endometrial RNA was also subjected to RT-PCR. However, no anchored oligo(dT) primer was used in the cDNA synthesis reaction for endometrial RNA. Only specific primers PR1 and PR2 were used in a single-step RT-PCR reaction to detect endometrial PR transcript (Titan One Tube RT-PCR System; Boehringer Mannheim). Primers for ␤ actin [19] were used in the same reaction to amplify actin as a positive control in the endometrial RNA sample. The program comprised 35 cycles of denaturation at 94ЊC for 30 sec, annealing at 52ЊC for 30 sec, and extension at 72ЊC for 2 min. The negative control did not include reverse transcriptase in the reaction mixture. The products were analyzed on a 1.2% agarose gel stained with ethidium bromide and visualized under UV transillumination. Reamplification of RT-PCR products of sperm PR was also carried out using PR1 and PR2 primers.
Sperm RNA was also subjected to RT-PCR using primers specific for leukocyte common antigen (CD45) [20] . RNA extracted from human leukocytes was also subjected to RT-PCR using PR-specific primers under conditions identical to those used for the detection of PR in human spermatozoa.
Southern Hybridization
The PR cDNA insert (hPR1/pSG5) of 3.8 kilobases (kb) was excised from the vector (3.9 kb) by EcoRI digestion. EcoRI-digested hPR1/pSG5 plasmid was run on a 5% polyacrylamide gel to elute the insert for PR [21] . The eluted fragment was labeled with nonradioactive digoxigenin-11-UTP (Boehringer Mannheim). In brief, 100 ng of the eluted fragment was labeled in a total volume of 20 l containing 2 l random hexamers, 2 l labeling mix, and 1 l of Klenow enzyme (digoxigenin DNA labeling kit; Boehringer Mannheim) at 37ЊC overnight. The labeled DNA was precipitated and washed with 70% ethanol. Concentration of the labeled DNA and the labeling efficiency was checked by comparing the intensities of colored precipitates formed by the prelabeled and labeled DNA samples in a colorimetric detection assay (Boehringer Mannheim) according to the manufacturer's instructions.
Sperm PR and endometrial PR RT-PCR products were transferred to nylon membranes [22] . Blots were prehybridized overnight at 40ЊC in 50% formamide, 6-strength SSC (single-strength SSC is 0.15 M sodium chloride, 0.015 M sodium citrate) pH 7.0, 5% blocking reagent, 0.1% N lauryl sarcosine, and 0.02% SDS and were hybridized for 20 h at 40ЊC with an optimized concentration (50 ng/ml) of digox- 
FIG. 4. PCR screening of recombinant pGEM-T colonies for the pres-
ence of the sperm PR clone. Lane M, HaeIII-digested ⌽X174 molecular size markers. Lanes 1-10 were loaded with products of PCRs using plasmid DNAs isolated from transformed colonies as templates and PR1 and PR2 as primers. Lane 11 contains the product of PCR using plasmid DNA isolated from full-length uterine PR cDNA clone as a template and PR1 and PR2 as primers.
igenin-labeled probe [23] . The filter was washed in doublestrength SSC, 0.1% SDS at room temperature three times for 30 min, and then in single-strength SSC, 0.1% SDS at 55ЊC, three times for 30 min. The hybridized molecules were detected using a nonradioactive chemiluminescent digoxigenin detection system (Boehringer Mannheim) according to the manufacturer's instructions.
Partial Cloning and Sequencing of Sperm PR
The RT-PCR product for sperm PR was eluted from a 1% agarose gel in 15% polyethylene glycol, precipitated, and washed with 70% ethanol. The eluted PCR fragment (60 ng) was ligated with 50 ng of pGEM-T vector in a 15-l reaction volume containing single-strength rapid ligation buffer and 1 Weiss unit of T4 DNA ligase at 25ЊC for 1 h (Promega, Madison, WI). The ligation product was transformed into DH5␣ competent cells, and 100 l of transformation mixture was plated on liquid broth medium/ampicillin (50 g/ml) with 5-bromo-4-chloro-3-indolyl ␤-D-galactopyranoside (X-Gal) and isopropyl-1-thio-ß-D-galactopyranoside (IPTG) to grow overnight. Ten colonies were selected for amplification in liquid broth medium/ampicillin. Plasmid DNAs were extracted from 1.5 ml of overnight-grown cultures by the alkaline lysis method [21] . Plasmid DNAs were subjected to PCR using primers PR1 and PR2. The positive clones were reamplified and sequenced using PR1 and PR2 primers (automated fluorescencebased DNA sequencing system).
RESULTS
When primers corresponding to the DNA binding and hormone binding domains of the conventional PR were used in RT-PCR to detect the PR transcript in human spermatozoa, no product was visualized (Fig. 1, lane 3) , whereas in endometrial RNA an intense band of expected size, i.e., 536 base pairs (bp) was seen (Fig. 1, lane 1) . However, when the transcripts from spermatozoa were reverse-transcribed using anchored oligo(dT) primers and then amplified with both forward and reverse PR-specific primers, a 536-bp product was obtained (Fig. 1, lane 4) . A few nonspecific signals were also observed that were due to the use of anchored oligo(dT) primers in the cDNA synthesis reaction. The intensity of these signals was less when the RT-PCR product of sperm PR was further amplified using only specific PR primers (Fig. 2, lane 1) . Sperm RNA subjected to RT-PCR using CD45-specific primers did not show any product (data not shown).
The identity of the PCR-amplified cDNA fragment of PR transcripts from human spermatozoa was verified using Southern hybridization with labeled full-length PR cDNA excised from hPR1/pSG5. Intense signals of 536 bp were observed for both sperm and endometrial PR (Fig. 3) .
The sperm PR PCR product was further cloned in pGEM-T vector. Recombinant clones were screened for the presence of an insert by PCR using specific primers PR1 and PR2 (Fig. 4) . Positive clones were subjected to automated fluorescence-based DNA sequencing using PR1 and FIG. 5 . Sequence of the sperm PR clone (from nucleotides 1-536) in pGEM-T vector as determined by an automated DNA sequencing system using PR1 and PR2 as sequencing primers. Sequences complementary to PR1 and PR2 primers are indicated in bold. Vector sequences are underlined.
PR2 as sequencing primers. The sperm PR-PCR product was identical in its sequence to the uterine PR cDNA from nucleotide 2694 to nucleotide 3230 [19] , thereby suggesting its similarity with uterine PR (Fig. 5) .
DISCUSSION
The present study demonstrates the presence of PR transcript in human spermatozoa. However, unlike uterine PR, the transcript seems to be present in low abundance, as indicated by our repeated inability to detect it by RT-PCR with specific PR primers, even with a high amount of initial template. However, when transcripts in spermatozoa were selectively transcribed using an anchored oligo(dT) primer, followed by amplification with primers spanning the DNA binding domain (as forward primer) and the hormone binding domain (as reverse primer) of the conventional PR, a PCR product of similar size (i.e., 536 bp) was obtained as expected for the endometrial PR. The product was not a result of any contamination in semen samples as the RNA was extracted from a motile sperm population collected by a swim-up procedure. The post-swim-up sperm sample was checked under ϫ400 magnification under a brightfield light microscope (Zeiss Ultraphot) to rule out the possibility of any contamination with other cells before the RNA was extracted. Although the sperm RNA preparation used in this study was obtained from a highly motile sperm population collected after a swim-up procedure, the sample was also subjected to RT-PCR using primers specific for CD45 to rule out the possibility of any cellular contamination. No product was detected for CD45 in sperm RNA. Further RNA samples extracted from human leukocytes when subjected to RT-PCR using PR primers did not demonstrate any PR product. The RT-PCR product for PR in sperm was also not a result of any DNA contamination as the RNA samples were subjected to DNase treatment before RT-PCR. Moreover, sequences of both primers were deduced from the cDNA sequence of the conventional PR, to avoid the amplification of intronic sequences. Further, we did not obtain any product when the reverse transcriptase was omitted from the amplification reaction carried out in presence of Taq polymerase alone.
The identity of the product was validated by Southern hybridization with a full-length cDNA probe for full-length uterine PR. This was further confirmed by sequencing of the sperm PR PCR product cloned in a T vector.
Our previous observations have shown that, unlike conventional PR, sperm PR is membrane protein and does not bind to mifepristone and other antiprogestins [11] . These observations were consistent with earlier reports demonstrating the inability of mifepristone and ZK 98.299 to block the progesterone-mediated increase in calcium influx in spermatozoa [3, 16] . They suggested the possibility that the sperm PR is distinct from the conventional PR. However, the present study demonstrates that the sequence of PR transcript from human spermatozoa is similar to that of PR transcript from human endometrium, at least in the region from nucleotide 2694 to nucleotide 3230 of the conventional PR cDNA. Although this study does not demonstrate detection of the full-length PR transcript in human spermatozoa, it clearly indicates that the sperm PR transcript has regions corresponding to both the domains-the DNA binding domain as well as hormone binding domain. However, this does not exclude the possibility that the PR transcript in spermatozoa is different from the conventional PR transcript in regions spanning nucleotides 1 to 2694 or 3231 to 3852, which may explain the differences in the binding characteristics of sperm PR with respect to ligand affinities, kinetics, and steroid specificities as compared to the conventional PR [7] .
Considering the fact that mature human spermatozoa have low biosynthetic activity, it seems likely that PR mRNA is synthesized in spermatid or other germ cells. However, to establish exactly the origin of PR synthesis in the process of maturation of spermatozoa in human, development of specific tools (antibodies/nucleic acids) to screen organ or tissue specific cDNA libraries is needed. The present study provides a sperm PR clone as a molecular tool for screening these libraries.
In conclusion, this study demonstrating the presence of PR transcript in mature human spermatozoa suggests a definite role for progesterone in sperm functions. It would be of interest to explore the presence of elements corresponding to the DNA binding domain of conventional PR and their function in sperm PR, which is a membrane protein and apparently does not require direct interaction with DNA to induce biological responses. These studies might throw some light on the possible existence of two alternate modes of action, i.e., genomic and nongenomic, of the progesterone-PR complex in spermatozoa.
